These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 32679249

  • 1. Potential antitumor activity of digitoxin and user-designed analog administered to human lung cancer cells.
    Eldawud R, Wagner A, Dong C, Gupta N, Rojanasakul Y, O'Doherty G, Stueckle TA, Dinu CZ.
    Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129683. PubMed ID: 32679249
    [Abstract] [Full Text] [Related]

  • 2. Real-time analysis of the effects of toxic, therapeutic and sub-therapeutic concentrations of digitoxin on lung cancer cells.
    Eldawud R, Stueckle TA, Manivannan S, Elbaz H, Chen M, Rojanasakul Y, Dinu CZ.
    Biosens Bioelectron; 2014 Sep 15; 59():192-9. PubMed ID: 24727605
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells.
    Elbaz HA, Stueckle TA, Wang HY, O'Doherty GA, Lowry DT, Sargent LM, Wang L, Dinu CZ, Rojanasakul Y.
    Toxicol Appl Pharmacol; 2012 Jan 01; 258(1):51-60. PubMed ID: 22037315
    [Abstract] [Full Text] [Related]

  • 5. Digitoxin and its synthetic analog MonoD have potent antiproliferative effects on lung cancer cells and potentiate the effects of hydroxyurea and paclitaxel.
    Yakisich JS, Azad N, Venkatadri R, Kulkarni Y, Wright C, Kaushik V, O'Doherty GA, Iyer AK.
    Oncol Rep; 2016 Feb 01; 35(2):878-86. PubMed ID: 26573786
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells.
    Nonpanya N, Prakhongcheep O, Petsri K, Jitjaicham C, Tungsukruthai S, Sritularak B, Chanvorachote P.
    Anticancer Res; 2020 Sep 01; 40(9):4989-4999. PubMed ID: 32878787
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumorigenic effects of a novel digitoxin derivative on both estrogen receptor-positive and triple-negative breast cancer cells.
    Kulkarni YM, Yakisich JS, Azad N, Venkatadri R, Kaushik V, O'Doherty G, Iyer AKV.
    Tumour Biol; 2017 Jun 01; 39(6):1010428317705331. PubMed ID: 28618929
    [Abstract] [Full Text] [Related]

  • 9. C3'/C4'-Stereochemical Effects of Digitoxigenin α-L-/α-D-Glycoside in Cancer Cytotoxicity.
    Hinds JW, McKenna SB, Sharif EU, Wang HY, Akhmedov NG, O'Doherty GA.
    ChemMedChem; 2013 Jan 01; 8(1):63-9. PubMed ID: 23139074
    [Abstract] [Full Text] [Related]

  • 10. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM, Saigal B, Talpaz M, Donato NJ.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by different growth factors.
    Trenti A, Zulato E, Pasqualini L, Indraccolo S, Bolego C, Trevisi L.
    Br J Pharmacol; 2017 Sep 01; 174(18):3094-3106. PubMed ID: 28688145
    [Abstract] [Full Text] [Related]

  • 12. The New Semisynthetic Cardenolide Analog 3β-[2-(1-Amantadine)-1-on-ethylamine]-digitoxigenin (AMANTADIG) Efficiently Suppresses Cell Growth in Human Leukemia and Urological Tumor Cell Lines.
    Nolte E, Sobel A, Wach S, Hertlein H, Ebert N, Müller-Uri F, Slany R, Taubert H, Wullich B, Kreis W.
    Anticancer Res; 2015 Oct 01; 35(10):5271-5. PubMed ID: 26408686
    [Abstract] [Full Text] [Related]

  • 13. Digitoxin synergizes with sorafenib to inhibit hepatocelluar carcinoma cell growth without inhibiting cell migration.
    Xiao Y, Yan W, Guo L, Meng C, Li B, Neves H, Chen PC, Li L, Huang Y, Kwok HF, Lin Y.
    Mol Med Rep; 2017 Feb 01; 15(2):941-947. PubMed ID: 28035421
    [Abstract] [Full Text] [Related]

  • 14. Compound Library Screening Identified Cardiac Glycoside Digitoxin as an Effective Growth Inhibitor of Gefitinib-Resistant Non-Small Cell Lung Cancer via Downregulation of α-Tubulin and Inhibition of Microtubule Formation.
    Zhang YZ, Chen X, Fan XX, He JX, Huang J, Xiao DK, Zhou YL, Zheng SY, Xu JH, Yao XJ, Liu L, Leung EL.
    Molecules; 2016 Mar 18; 21(3):374. PubMed ID: 26999101
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
    Klimaszewska-Wiśniewska A, Hałas-Wiśniewska M, Grzanka A, Grzanka D.
    Int J Mol Sci; 2018 Feb 27; 19(3):. PubMed ID: 29495431
    [Abstract] [Full Text] [Related]

  • 16. Autophagy-Induced Apoptosis in Lung Cancer Cells by a Novel Digitoxin Analog.
    Kulkarni YM, Kaushik V, Azad N, Wright C, Rojanasakul Y, O'Doherty G, Iyer AK.
    J Cell Physiol; 2016 Apr 27; 231(4):817-28. PubMed ID: 26264876
    [Abstract] [Full Text] [Related]

  • 17. Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer.
    Lin SY, Chang HH, Lai YH, Lin CH, Chen MH, Chang GC, Tsai MF, Chen JJ.
    PLoS One; 2015 Apr 27; 10(5):e0123305. PubMed ID: 25955608
    [Abstract] [Full Text] [Related]

  • 18. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L, Han S, Jiao Y, Jiang S, He X, Li P.
    Int J Oncol; 2017 Jul 27; 51(1):25-38. PubMed ID: 28534943
    [Abstract] [Full Text] [Related]

  • 19. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI, Hong JY, Lee HJ, Bae SY, Jung C, Park HJ, Lee SK.
    PLoS One; 2015 Jul 27; 10(12):e0144368. PubMed ID: 26656173
    [Abstract] [Full Text] [Related]

  • 20. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
    Chikara S, Lindsey K, Borowicz P, Christofidou-Solomidou M, Reindl KM.
    BMC Complement Altern Med; 2017 Jan 09; 17(1):30. PubMed ID: 28068967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.